JP2023537326A5 - - Google Patents

Info

Publication number
JP2023537326A5
JP2023537326A5 JP2023506494A JP2023506494A JP2023537326A5 JP 2023537326 A5 JP2023537326 A5 JP 2023537326A5 JP 2023506494 A JP2023506494 A JP 2023506494A JP 2023506494 A JP2023506494 A JP 2023506494A JP 2023537326 A5 JP2023537326 A5 JP 2023537326A5
Authority
JP
Japan
Prior art keywords
acid sequence
car
amino acid
seq
muc1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023506494A
Other languages
English (en)
Japanese (ja)
Other versions
JP7719855B2 (ja
JP2023537326A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/071017 external-priority patent/WO2022027039A1/en
Publication of JP2023537326A publication Critical patent/JP2023537326A/ja
Publication of JP2023537326A5 publication Critical patent/JP2023537326A5/ja
Priority to JP2024105523A priority Critical patent/JP2024156662A/ja
Application granted granted Critical
Publication of JP7719855B2 publication Critical patent/JP7719855B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023506494A 2020-07-29 2021-07-27 抗可変ｍｕｃ１＊抗体およびその使用 Active JP7719855B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024105523A JP2024156662A (ja) 2020-07-29 2024-06-28 抗可変ｍｕｃ１＊抗体およびその使用

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202063058044P 2020-07-29 2020-07-29
US63/058,044 2020-07-29
US202063122234P 2020-12-07 2020-12-07
US63/122,234 2020-12-07
US202163151380P 2021-02-19 2021-02-19
US63/151,380 2021-02-19
US202163173083P 2021-04-09 2021-04-09
US63/173,083 2021-04-09
US202163184724P 2021-05-05 2021-05-05
US63/184,724 2021-05-05
PCT/US2021/071017 WO2022027039A1 (en) 2020-07-29 2021-07-27 Anti-variable muc1* antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024105523A Division JP2024156662A (ja) 2020-07-29 2024-06-28 抗可変ｍｕｃ１＊抗体およびその使用

Publications (3)

Publication Number Publication Date
JP2023537326A JP2023537326A (ja) 2023-08-31
JP2023537326A5 true JP2023537326A5 (https=) 2024-02-06
JP7719855B2 JP7719855B2 (ja) 2025-08-06

Family

ID=80036184

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023506494A Active JP7719855B2 (ja) 2020-07-29 2021-07-27 抗可変ｍｕｃ１＊抗体およびその使用
JP2024105523A Pending JP2024156662A (ja) 2020-07-29 2024-06-28 抗可変ｍｕｃ１＊抗体およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024105523A Pending JP2024156662A (ja) 2020-07-29 2024-06-28 抗可変ｍｕｃ１＊抗体およびその使用

Country Status (8)

Country Link
EP (1) EP4188959A4 (https=)
JP (2) JP7719855B2 (https=)
KR (1) KR20230059789A (https=)
CN (1) CN116234828A (https=)
AU (1) AU2021316042A1 (https=)
CA (1) CA3187555A1 (https=)
IL (1) IL300252A (https=)
WO (1) WO2022027039A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120484122A (zh) 2019-01-11 2025-08-15 米纳瓦生物技术公司 抗可变muc1*抗体及其用途
WO2020232247A1 (en) 2019-05-14 2020-11-19 Provention Bio, Inc. Methods and compositions for preventing type 1 diabetes
IL298999A (en) 2020-06-11 2023-02-01 Provention Bio Inc Methods and compositions for the prevention of type 1 diabetes
CA3183682A1 (en) 2020-06-26 2021-12-30 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
JP2024520444A (ja) 2021-05-24 2024-05-24 プロヴェンション・バイオ・インコーポレイテッド １型糖尿病を治療するための方法
CN119317447A (zh) 2022-04-12 2025-01-14 米纳瓦生物技术公司 抗可变muc1*抗体及其用途
US20240261406A1 (en) 2023-02-02 2024-08-08 Minerva Biotechnologies Corporation Chimeric antigen receptor compositions and methods for treating muc1* diseases
WO2025049494A1 (en) 2023-08-29 2025-03-06 Minerva Biotechnologies Corporation Bacterial nme7 orthologs and uses thereof
US20250121088A1 (en) * 2023-10-11 2025-04-17 Minerva Biotechnologies Corporation Anti-muc1* antibody drug complexes and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116199790A (zh) * 2015-02-10 2023-06-02 米纳瓦生物技术公司 人源化抗MUCl*抗体
WO2019104306A1 (en) * 2017-11-27 2019-05-31 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies and direct use of cleavage enzyme
JP7416695B2 (ja) * 2017-12-29 2024-01-17 メモリアル スローン－ケタリング キャンサー センター 増強されたキメラ抗原受容体およびその使用
CN120484122A (zh) * 2019-01-11 2025-08-15 米纳瓦生物技术公司 抗可变muc1*抗体及其用途

Similar Documents

Publication Publication Date Title
JP2023537326A5 (https=)
JP2022527144A5 (https=)
JP2021094037A5 (https=)
JP2021087455A5 (https=)
JP2023059873A5 (https=)
JP2019527557A5 (https=)
JP2020513754A5 (https=)
JP2025028239A5 (https=)
JP2018525033A5 (https=)
JP2020529841A5 (https=)
JP2023534808A5 (https=)
JP2022501043A5 (https=)
EP3472205B1 (en) Chimeric antigen receptor
JP2018508219A5 (https=)
JP2020513829A5 (https=)
JP2021177771A5 (https=)
JP2022113880A5 (https=)
JP2023071729A5 (https=)
JP2020533958A5 (https=)
JP2024507996A5 (https=)
JP2017518071A5 (https=)
FI3710067T3 (fi) Polypeptidejä sisältävä d-domeeni ja niiden käyttötarkoitukset
RU2018109426A (ru) Химерные антигенные рецепторы со встроенными контролируемыми функциями
JP2024023228A5 (https=)
FI4063397T3 (fi) Yksidomeenivasta-aineisiin perustuvia antigeenireseptoreita ja menetelmiä niiden käyttämiseksi